CRBU vs. VB
CRBU (Caribou Biosciences, Inc.) is a stock, while VB (Vanguard Small-Cap ETF) is Small Cap Blend Equities fund tracking the CRSP US Small Cap Index. Over the past 3 years, CRBU returned -37.96%/yr vs 14.39%/yr for VB. At a 0.47 correlation, their price movements are largely independent.
Performance
CRBU vs. VB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBU achieves a 3.77% return, which is significantly lower than VB's 15.61% return.
CRBU
- 1D
- -0.60%
- 1M
- 0.61%
- 6M
- 13.01%
- YTD
- 3.77%
- 1Y
- -9.84%
- 3Y*
- -37.96%
- 5Y*
- —
- 10Y*
- —
VB
- 1D
- -0.57%
- 1M
- 1.38%
- 6M
- 8.24%
- YTD
- 15.61%
- 1Y
- 23.22%
- 3Y*
- 14.39%
- 5Y*
- 8.19%
- 10Y*
- 11.11%
CRBU vs. VB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRBU Caribou Biosciences, Inc. | 3.77% | 0.00% | -72.25% | -8.76% | -58.38% | -14.50% |
VB Vanguard Small-Cap ETF | 15.61% | 8.87% | 14.17% | 18.22% | -17.51% | 4.07% |
Correlation
The correlation between CRBU and VB is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since Jul 23, 2021 | 0.47 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBU vs. VB — Risk / Return Rank
CRBU
VB
CRBU vs. VB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and Vanguard Small-Cap ETF (VB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRBU | VB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.55 | ||
| Sortino ratioReturn per unit of downside risk | -1.71 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.25 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.19 | 2.60 | -2.79 |
| Martin ratioReturn relative to average drawdown | -0.31 | 9.45 | -9.76 |
Loading charts...
Drawdowns
CRBU vs. VB - Drawdown Comparison
The maximum CRBU drawdown since its inception was -97.58%, which is greater than VB's maximum drawdown of -59.56%. Use the drawdown chart below to compare losses from any high point for CRBU and VB.
Loading charts...
Drawdown Indicators
| CRBU | VB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.58% | -59.56% | -38.02% |
Max Drawdown (1Y)Largest decline over 1 year | -51.06% | -8.98% | -42.08% |
Max Drawdown (3Y)Largest decline over 3 years | -91.12% | -25.36% | -65.76% |
Max Drawdown (5Y)Largest decline over 5 years | — | -28.15% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.05% | — |
Current DrawdownCurrent decline from peak | -94.55% | -2.28% | -92.27% |
Average DrawdownAverage peak-to-trough decline | -79.59% | -8.40% | -71.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.65% | 2.46% | +29.19% |
Volatility
CRBU vs. VB - Volatility Comparison
Caribou Biosciences, Inc. (CRBU) has a higher volatility of 15.29% compared to Vanguard Small-Cap ETF (VB) at 3.37%. This indicates that CRBU's price experiences larger fluctuations and is considered to be riskier than VB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBU | VB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.29% | 3.37% | +11.92% |
Volatility (6M)Calculated over the trailing 6-month period | 50.46% | 12.08% | +38.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.91% | 16.48% | +61.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.28% | 20.74% | +65.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.28% | 21.36% | +64.92% |
Dividends
CRBU vs. VB - Dividend Comparison
CRBU has not paid dividends to shareholders, while VB's dividend yield for the trailing twelve months is around 1.22%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBU Caribou Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VB Vanguard Small-Cap ETF | 1.22% | 1.33% | 1.30% | 1.55% | 1.59% | 1.24% | 1.14% | 1.39% | 1.67% | 1.35% | 1.50% | 1.48% |
Frequently Asked Questions
CRBU and VB have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRBU has higher volatility (15.29%) compared to VB (3.37%). In terms of maximum drawdown, CRBU dropped -97.58% vs VB's -59.56%.
VB currently has the higher Sharpe Ratio (1.42 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBU and VB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer